Literature DB >> 17897577

Treatment options in pediatric GERD.

Neelesh A Tipnis1, Colin D Rudolph.   

Abstract

Gastroesophageal reflux (GER) is a common physiologic phenomenon in infants and children. GER that results in symptoms or complications--hence the evolution to GER disease (GERD)--warrants targeted evaluation and appropriate treatment. Judicious use of acid-suppression therapy remains the mainstay of pharmacologic treatment of GERD. However, recognition of treatment goals and potentials risks of acid suppression must be considered prior to initiation of therapy. The role of surgical intervention for GERD remains limited.

Entities:  

Year:  2007        PMID: 17897577     DOI: 10.1007/s11938-007-0039-6

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  50 in total

Review 1.  Pharmacotherapy of spasticity: oral medications and intrathecal baclofen.

Authors:  L E Krach
Journal:  J Child Neurol       Date:  2001-01       Impact factor: 1.987

2.  Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.

Authors:  Sandra Dial; J A C Delaney; Alan N Barkun; Samy Suissa
Journal:  JAMA       Date:  2005-12-21       Impact factor: 56.272

3.  Effects of thickened feeding on gastroesophageal reflux in infants: a placebo-controlled crossover study using intraluminal impedance.

Authors:  Tobias G Wenzl; Sabine Schneider; Frank Scheele; Jiri Silny; Gerhard Heimann; Heino Skopnik
Journal:  Pediatrics       Date:  2003-04       Impact factor: 7.124

4.  One-week omeprazole treatment in the diagnosis of gastro-oesophageal reflux disease.

Authors:  F Johnsson; L Weywadt; J H Solhaug; H Hernqvist; L Bengtsson
Journal:  Scand J Gastroenterol       Date:  1998-01       Impact factor: 2.423

Review 5.  Canadian Helicobacter Study Group Consensus Conference: Update on the approach to Helicobacter pylori infection in children and adolescents--an evidence-based evaluation.

Authors:  Billy Bourke; Peter Ceponis; Naoki Chiba; Steve Czinn; Richard Ferraro; Lori Fischbach; Ben Gold; Hien Hyunh; Kevan Jacobson; Nicola L Jones; Sibylle Koletzko; Sylvie Lebel; Paul Moayyedi; Robert Ridell; Philip Sherman; Sander van Zanten; Ivan Beck; Linda Best; Margaret Boland; Ford Bursey; Hugh Chaun; Geraldine Cooper; Brian Craig; Carole Creuzenet; Jeffrey Critch; Krishnasamy Govender; Eric Hassall; Alan Kaplan; Monica Keelan; Garth Noad; Marli Robertson; Lesley Smith; Markus Stein; Diane Taylor; Thomas Walters; Robin Persaud; Scott Whitaker; Robert Woodland
Journal:  Can J Gastroenterol       Date:  2005-07       Impact factor: 3.522

6.  Guidelines for evaluation and treatment of gastroesophageal reflux in infants and children: recommendations of the North American Society for Pediatric Gastroenterology and Nutrition.

Authors:  C D Rudolph; L J Mazur; G S Liptak; R D Baker; J T Boyle; R B Colletti; W T Gerson; S L Werlin
Journal:  J Pediatr Gastroenterol Nutr       Date:  2001       Impact factor: 2.839

7.  Rebound acid hypersecretion after long-term inhibition of gastric acid secretion.

Authors:  R Fossmark; G Johnsen; E Johanessen; H L Waldum
Journal:  Aliment Pharmacol Ther       Date:  2005-01-15       Impact factor: 8.171

8.  Natural history and familial relationships of infant spilling to 9 years of age.

Authors:  A James Martin; Nicole Pratt; J Declan Kennedy; Philip Ryan; Richard E Ruffin; Helen Miles; John Marley
Journal:  Pediatrics       Date:  2002-06       Impact factor: 7.124

9.  Vitamin B(12) deficiency associated with histamine(2)-receptor antagonists and a proton-pump inhibitor.

Authors:  J Mark Ruscin; Robert Lee Page; Robert J Valuck
Journal:  Ann Pharmacother       Date:  2002-05       Impact factor: 3.154

10.  Mechanisms of gastroesophageal reflux in children.

Authors:  S L Werlin; W J Dodds; W J Hogan; R C Arndorfer
Journal:  J Pediatr       Date:  1980-08       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.